Syneos Health Denmark ApS

CVR 35416838 · Private limited company (ApS) · Active · Low risk

Syneos Health Denmark ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 12 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 9.0m and a net result of DKK 1.3m. CEO: Emma Louise Reuberson, Elisabeth Maria Trost.

Bankruptcy risk for Syneos Health Denmark ApS

0.1%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 27% of active Danish companies

Lowest riskHighest risk

Increases the risk

RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×
Postcode changes3+ · bankruptcy rate 10.2%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Gross profit growth0%–10% · bankruptcy rate 3.5%0.39×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
35416838
Status
Active
Company type
Private limited company (ApS)
Founded
(13 years)
Address
Bredgade 30
1260 København K
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 80k
Employees
16 (2018)
Auditor
AIDER Godkendt Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late3 of 12
Missing annual reportNo
Negative equityNo
Equity ratio71.0%
Current ratio344%
Moves (last 2 years)0
CEO changes in total8
CEO's previous bankruptcies0
Other companies at the address221
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 20.8mDKK 20.0m
Net profitDKK 1.3mDKK 935k
EquityDKK 9.0mDKK 7.7m
Total assetsDKK 12.7mDKK 11.9m
CashDKK 4.3m–
Short-term debtDKK 3.7m–
Tax owedDKK 211k–
Avg. employees20–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Baker Tilly Denmark.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025179
1 Jan 2024 – 31 Dec 2024178
1 Jan 2023 – 31 Dec 2023180
1 Jan 2022 – 31 Dec 2022181
1 Jan 2021 – 31 Dec 2021188 Late
1 Jan 2020 – 31 Dec 2020189 Late
1 Jan 2019 – 31 Dec 2019155
1 Jan 2018 – 31 Dec 2018162
1 Jan 2017 – 31 Dec 2017151
1 Jan 2016 – 31 Dec 2016151
1 Jan 2015 – 31 Dec 201591
19 Aug 2013 – 31 Dec 2014189 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOEmma Louise ReubersonCurrent
CEOElisabeth Maria TrostCurrent
CEOBent Kemplar
CEOMark James Cooper
CEOKaren Anne Turner
CEOKirstin Maura Mackenzie Connell
BoardEric Mitchell Sherbet
BoardTrevor Paul Hanbury
BoardElisabeth Maria Trost
BoardKaren Anne Turner
BoardKirstin Maura Mackenzie Connell
BoardEmma Louise Reuberson
Owner (100%)Syneos Health Switzerland GmbHCurrent
AuditorAIDER Godkendt RevisionsaktieselskabCurrent
AuditorForvis Mazars Statsautoriseret Revisionspartnerselskab
AuditorMoore Denmark, Statsautoriseret Revisionsaktieselskab
AuditorRSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderKR 332 ApSCurrent

The CEOs' other companies

Bent Kemplar – 51 other companies, of which 22 bankrupt

Address history (5 moves)

Bredgade 30, 1260 København K
c/o Baker Tilly Denmark, Poul Bundgaards Vej 1, 1., 2500 Valby
c/o Beierholm, Knud Højgaards Vej 9, 2860 Søborg
c/o Moore Stephens Danmark, Nørre Farimagsgade 11, 1364 København K
c/o CorpNordic Denmark A/S, Harbour House, Sundkrogsgade 21, 2100 København Ø
c/o Kromann Reumert, Sundkrogsgade 5, 2100 København Ø

Former names

Syneos Health Denmark ApS – now
INVENTIV HEALTH CLINICAL DENMARK ApS –
KR 1731 ApS –

Employees per year

Number of employees at Syneos Health Denmark ApS per year8162013: 020132014: 620142015: 720152016: 820162017: 620172018: 162018

Other companies at the same address

Similar companies in København

Questions and answers about Syneos Health Denmark ApS

Has Syneos Health Denmark ApS gone bankrupt?

No, Syneos Health Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Syneos Health Denmark ApS?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of Syneos Health Denmark ApS?

Emma Louise Reuberson, Elisabeth Maria Trost are the CEOs of Syneos Health Denmark ApS.

Who is the auditor of Syneos Health Denmark ApS?

Syneos Health Denmark ApS most recently used AIDER Godkendt Revisionsaktieselskab.

When was Syneos Health Denmark ApS founded?

Syneos Health Denmark ApS was founded on 19 August 2013.

What is the equity of Syneos Health Denmark ApS?

Equity was DKK 9.0m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.